Nuveen Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $35.7M | Sell |
3,013,533
-171,939
| -5% | -$2.03M | 0.01% | 828 |
|
|
2024
Q3 | $36.8M | Buy |
3,185,472
+17,492
| +0.6% | +$202K | 0.01% | 816 |
|
|
2024
Q2 | $33.5M | Buy |
3,167,980
+812,468
| +34% | +$8.59M | 0.01% | 828 |
|
|
2024
Q1 | $24.8M | Sell |
2,355,512
-18,403
| -0.8% | -$194K | 0.01% | 1040 |
|
|
2023
Q4 | $26.7M | Buy |
2,373,915
+940,315
| +66% | +$10.6M | 0.01% | 961 |
|
|
2023
Q3 | $16.7M | Buy |
1,433,600
+697,011
| +95% | +$8.14M | 0.01% | 1139 |
|
|
2023
Q2 | $7.42M | Buy |
+736,589
| New | +$7.42M | ﹤0.01% | 1675 |
|